Lisa Ricciardi, president and CEO of Cognition Therapeutics was recently a guest on Benzinga's All-Access. Cognition ...

Geode Capital Management LLC lifted its position in Vigil Neuroscience, Inc. (NASDAQ:VIGL – Free Report) by 41.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 226,083 shares of the ...

Universal Brain, a pioneering technology company focused on transforming mental healthcare through neuroscience, today announced t ...

NYSE:ANRO) Alto Neuroscience Inc Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm ...

Neuroscience Innovation Forum14th Annual LifeSci Advisors Corporate Access EventInvest Securities BioMed Forum 2025MidCap Events Frankfurt 2025Bio-Neuroscience 2025 MADRID and CAMBRIDGE, Mass., Jan.

Vistagen , a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced enrollment of the first subject in a repeat dose study of ...

Psylo, a leader in neurotherapeutics discovery and development, has officially rebranded as Xylo Bio. This transformation reflects the company's growth, sharpened focus on neuroscience, and commitment ...

The Afference Ring kind of acts like a middle man to this. Conductive contacts around the inside of the ring create the ...

At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient ...

In a report released today, Richard Vosser from J.P. Morgan maintained a Sell rating on Roche Holding AG (RHHVF – Research Report), with a ...

Novartis faces short-term challenges with patent expirations but shows long-term growth potential. Click here to read why I ...

In a report released today, Mohit Bansal from Wells Fargo assigned a Hold rating to Amgen (AMGN – Research Report), with a price target of ...